359 related articles for article (PubMed ID: 19307104)
1. The weight of interleukin-6 in B cell-related autoimmune disorders.
Youinou P; Jamin C
J Autoimmun; 2009; 32(3-4):206-10. PubMed ID: 19307104
[TBL] [Abstract][Full Text] [Related]
2. Expression of CD5 and CD23 on B cells of patients with rheumatoid arthritis, systemic lupus erythematosus and Sjögren's syndrome. Relationship with disease activity and treatment.
Ebo D; DeClerck LS; Bridts CH; Stevens WJ
In Vivo; 1994; 8(4):577-80. PubMed ID: 7534494
[TBL] [Abstract][Full Text] [Related]
3. B-cell depletion in autoimmune diseases. Advances in autoimmunity.
Guzman Moreno R
Autoimmun Rev; 2009 Jun; 8(7):585-90. PubMed ID: 19393204
[TBL] [Abstract][Full Text] [Related]
4. BAFF overexpression is associated with autoantibody production in autoimmune diseases.
Pers JO; Daridon C; Devauchelle V; Jousse S; Saraux A; Jamin C; Youinou P
Ann N Y Acad Sci; 2005 Jun; 1050():34-9. PubMed ID: 16014518
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-6 is responsible for aberrant B-cell receptor-mediated regulation of RAG expression in systemic lupus erythematosus.
Hillion S; Garaud S; Devauchelle V; Bordron A; Berthou C; Youinou P; Jamin C
Immunology; 2007 Nov; 122(3):371-80. PubMed ID: 17608810
[TBL] [Abstract][Full Text] [Related]
6. Antibody-dependent cell-mediated cytotoxicity in selected autoimmune diseases.
Feldmann JL; Becker MJ; Moutsopoulos H; Fye K; Blackman M; Epstein WV; Talal N
J Clin Invest; 1976 Jul; 58(1):173-9. PubMed ID: 6490
[TBL] [Abstract][Full Text] [Related]
7. Peripheral expression of RAG in human B lymphocytes in normal and pathological conditions is dependent on interleukin-6.
Hillion S; Youinou P; Jamin C
Autoimmun Rev; 2007 Jun; 6(6):415-20. PubMed ID: 17537388
[TBL] [Abstract][Full Text] [Related]
8. Soluble interleukin-6 receptor in plasma and in lymphocyte culture supernatants of healthy individuals and patients with systemic lupus erythematosus and rheumatoid arthritis.
Polgár A; Brózik M; Tóth S; Holub M; Hegyi K; Kádár A; Hodinka L; Falus A
Med Sci Monit; 2000; 6(1):13-8. PubMed ID: 11208277
[TBL] [Abstract][Full Text] [Related]
9. B-cell targeted therapies in rheumatoid arthritis and systemic lupus erythematosus.
Eisenberg R; Albert D
Nat Clin Pract Rheumatol; 2006 Jan; 2(1):20-7. PubMed ID: 16932648
[TBL] [Abstract][Full Text] [Related]
10. Transmembrane BAFF from rheumatoid synoviocytes requires interleukin-6 to induce the expression of recombination-activating gene in B lymphocytes.
Rochas C; Hillion S; Saraux A; Mageed RA; Youinou P; Jamin C; Devauchelle V
Arthritis Rheum; 2009 May; 60(5):1261-71. PubMed ID: 19404965
[TBL] [Abstract][Full Text] [Related]
11. [Regulatory T cells and systemic autoimmune diseases: systemic lupus erythematosus, rheumatoid arthritis, primary Sjögren's syndrome].
Bernard F; Romano A; Granel B
Rev Med Interne; 2010 Feb; 31(2):116-27. PubMed ID: 19962219
[TBL] [Abstract][Full Text] [Related]
12. BAFF and rheumatic autoimmune disorders: implications for disease management and therapy.
Bosello S; Pers JO; Rochas C; Devauchelle V; De Santis M; Daridon C; Saraux A; Ferraccioli GF; Youinou P
Int J Immunopathol Pharmacol; 2007; 20(1):1-8. PubMed ID: 17346422
[TBL] [Abstract][Full Text] [Related]
13. Involvement of apoptotic cell death in autoimmune diseases.
Kawakami A; Eguchi K
Med Electron Microsc; 2002 Mar; 35(1):1-8. PubMed ID: 12111401
[TBL] [Abstract][Full Text] [Related]
14. RAG-mediated secondary rearrangements of B-cell antigen receptors in rheumatoid synovial tissue.
Rochas C; Hillion S; Youinou P; Jamin C; Devauchelle-Pensec V
Autoimmun Rev; 2007 Dec; 7(2):155-9. PubMed ID: 18035327
[TBL] [Abstract][Full Text] [Related]
15. CD5+ B lymphocytes in systemic lupus erythematosus and rheumatoid arthritis.
Smith HR; Olson RR
J Rheumatol; 1990 Jun; 17(6):833-5. PubMed ID: 1696993
[TBL] [Abstract][Full Text] [Related]
16. Post-mortem prevalence of lymphocytic infiltration of the lacrymal gland: a comparative study in autoimmune and non-autoimmune diseases.
Nasu M; Matsubara O; Yamamoto H
J Pathol; 1984 May; 143(1):11-5. PubMed ID: 6737113
[TBL] [Abstract][Full Text] [Related]
17. Relationship of Sjögren's syndrome to other connective tissue and autoimmune disorders.
Theander E; Jacobsson LT
Rheum Dis Clin North Am; 2008 Nov; 34(4):935-47, viii-ix. PubMed ID: 18984413
[TBL] [Abstract][Full Text] [Related]
18. New treatments for SLE: cell-depleting and anti-cytokine therapies.
Anolik JH; Aringer M
Best Pract Res Clin Rheumatol; 2005 Oct; 19(5):859-78. PubMed ID: 16150407
[TBL] [Abstract][Full Text] [Related]
19. [B lymphocyte stimulator (BLyS) and monocytes: possible role in autoimmune diseases with a particular reference to rheumatoid arthritis].
Quartuccio L; Fabris M; Ferraccioli G
Reumatismo; 2004; 56(3):143-6. PubMed ID: 15470519
[TBL] [Abstract][Full Text] [Related]
20. Systemic autoimmune diseases in patients with hepatitis C virus infection: characterization of 1020 cases (The HISPAMEC Registry).
Ramos-Casals M; Muñoz S; Medina F; Jara LJ; Rosas J; Calvo-Alen J; Brito-Zerón P; Forns X; Sánchez-Tapias JM;
J Rheumatol; 2009 Jul; 36(7):1442-8. PubMed ID: 19369460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
